Drzayich Antol D, Waldman Casebeer A, Khoury R, et al. The relationship between comorbidity medication adherence and health related quality of life among patients with cancer. J Patient-Reported Outcomes. 2018;2:29.

Article  Google Scholar 

Sabaté E. Adherence to long-term therapies: evidence for action. World Health Organization. 2003. http://apps.who.int/iris/bitstream/handle/10665/42682/9241545992.pdf?sequence=1. Accessed 1 Jan 2022.

Unnikrishnan R, Veeraiah S, Mani S, et al. Comprehensive Evaluation of Adherence to Therapy, Its Associations, and Its Implications in Patients With Chronic Myeloid Leukemia Receiving Imatinib. Clin Lymphoma Myeloma Leuk. 2016;16(6):366-371.e363.

Article  PubMed  Google Scholar 

Makubate B, Donnan PT, Dewar JA, Thompson AM, McCowan C. Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality. Br J Cancer. 2013;108(7):1515–24.

Article  CAS  PubMed  PubMed Central  Google Scholar 

McCowan C, Shearer J, Donnan PT, et al. Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer. Br J Cancer. 2008;99(11):1763–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Butow P, Palmer S, Pai A, Goodenough B, Luckett T, King M. Review of adherence-related issues in adolescents and young adults with cancer. J Clin Oncol : Off J Am Soc Clin Oncol. 2010;28(32):4800–9.

Kyngas H, Duffy ME, Kroll T. Conceptual analysis of compliance. J Clin Nurs. 2000;9(1):5–12.

Article  CAS  PubMed  Google Scholar 

Coccia PF, Pappo AS, Beaupin L, et al. Adolescent and Young Adult Oncology, Version 22018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw. 2018;16(1):66–97.

Article  Google Scholar 

Albritton K, Caligiuri M, Anderson B, Nichols C, Ulman D. Closing the gap: research and care imperatives for adolescents and young adults with cancer. National Institutes of Health, National Cancer Institute, and LIVESTRONG Young Adult Alliance. 2006. https://www.livestrong.org/sites/default/files/what-wedo/reports/ayao_prg_report_2006_final.pdf. Accessed 1 Jan 2022.

Marin D, Bazeos A, Mahon FX, et al. Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib. J Clin Oncol. 2010;28(14):2381–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ibrahim AR, Eliasson L, Apperley JF, et al. Poor adherence is the main reason for loss of CCyR and imatinib failure for chronic myeloid leukemia patients on long-term therapy. Blood. 2011;117(14):3733–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Noens L, van Lierde MA, De Bock R, et al. Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study. Blood. 2009;113(22):5401–11.

Article  CAS  PubMed  Google Scholar 

Dezentje VO, van Blijderveen NJ, Gelderblom H, et al. Effect of concomitant CYP2D6 inhibitor use and tamoxifen adherence on breast cancer recurrence in early-stage breast cancer. J Clin Oncol. 2010;28(14):2423–9.

Article  CAS  PubMed  Google Scholar 

Bhatia S, Landier W, Hageman L, et al. Systemic Exposure to Thiopurines and Risk of Relapse in Children With Acute Lymphoblastic Leukemia: A Children’s Oncology Group Study. JAMA Oncol. 2015;1(3):287–95.

Bhatia S, Landier W, Shangguan M, et al. Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non-Hispanic white children with acute lymphoblastic leukemia: a report from the children’s oncology group. J Clin Oncol. 2012;30(17):2094–101.

Pasvolsky O, Shimony S, Yeshurun M, et al. Maintenance therapy after allogeneic hematopoietic transplant for acute myeloid leukemia: a systematic review and meta-analysis. Acta Oncol. 2021;60(10):1335–41.

Article  CAS  PubMed  Google Scholar 

Burchert A, Bug G, Fritz LV, et al. Sorafenib maintenance after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia with FLT3–internal tandem duplication mutation (SORMAIN). J Clin Oncol. 2020;38(26):2993–3002.

Article  PubMed  Google Scholar 

Davies C, Pan H, Godwin J, et al. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. The Lancet. 2013;381(9869):805–16.

Article  CAS  Google Scholar 

LHRH-agonists in Early Breast Cancer Overview group. Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials. The Lancet. 2007;369(9574):1711–23.

Article  Google Scholar 

Betts AC, Murphy CC, Shay LA, Balasubramanian BA, Markham C, Allicock M. Polypharmacy and prescription medication use in a population-based sample of adolescent and young adult cancer survivors. [published online ahead of print, 2022 Jan 8]. J Cancer Surviv. 2022. https://doi.org/10.1007/s11764-021-01161-0.

Kaul S, Veeranki SP, Rodriguez AM, Kuo YF. Cigarette smoking, comorbidity, and general health among survivors of adolescent and young adult cancer. Cancer. 2016;122(18):2895–905.

Article  PubMed  Google Scholar 

Chao C, Bhatia S, Xu L, et al. Chronic comorbidities among survivors of adolescent and young adult cancer. J Clin Oncol : Off J Am Soc Clin Oncol. 2020;38(27):3161–74.

Wu XC, Prasad PK, Landry I, et al. Impact of the AYA HOPE comorbidity index on assessing health care service needs and health status among adolescents and young adults with cancer. Cancer Epidemol Biomarkers Prev. 2015;24(12):1844–9.

Article  Google Scholar 

Chao C, Xu L, Bhatia S, et al. Cardiovascular disease risk profiles in survivors of adolescent and young adult (AYA) cancer: the Kaiser Permanente AYA Cancer Survivors Study. J Clin Oncol. 2016;34(14):1626–33.

Article  CAS  PubMed  Google Scholar 

Hsu CD, Nichols HB, Lund JL. Polypharmacy and medication use by cancer history in a nationally representative group of adults in the USA, 2003–2014. J Cancer Surviv. 2022;16(3):659–66.

McGrady ME, Pai ALH. A Systematic Review of Rates, Outcomes, and Predictors of Medication Non-Adherence Among Adolescents and Young Adults with Cancer. J Adolesc Young Adult Oncol. 2019;8(5):485–94.

Article  PubMed  PubMed Central  Google Scholar 

Kaul S, Avila JC, Mehta HB, Rodriguez AM, Kuo YF, Kirchhoff AC. Cost-related medication nonadherence among adolescent and young adult cancer survivors. Cancer. 2017;123(14):2726–34.

Article  CAS  PubMed  Google Scholar 

Hershman DL, Shao T, Kushi LH, et al. Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat. 2011;126(2):529–37.

Article  CAS  PubMed  Google Scholar 

Kennard BD, Stewart SM, Olvera R, Bawdon RE, Lewis CP, Winick NJ. Nonadherence in adolescent oncology patients: preliminary data on psychological risk factors and relationships to outcome. J Clin Psychol Med Settings. 2004;11(1):31–9.

Article  Google Scholar 

Hullmann SE, Brumley LD, Schwartz LA. Medical and psychosocial associates of nonadherence in adolescents with cancer. J Pediatr Oncol Nurs : Off J Assoc Pediatr Oncol Nurs. 2015;32(2):103–13.

Tamaroff MH, Festa RS, Adesman AR, Walco GA. Therapeutic adherence to oral medication regimens by adolescents with cancer. II. Clinical and psychologic correlates. J Pediatr. 1992;120(5):812–7.

Article  CAS  PubMed  Google Scholar 

Linder LA, Wu YP, Macpherson CF, et al. Oral medication adherence among adolescents and young adults with cancer before and following use of a smartphone-based medication reminder app. J Adolesc Young Adult Oncol. 2019;8(2):122–30.

Article  PubMed  PubMed Central  Google Scholar 

Lau RC, Matsui D, Greenberg M, Koren G. Electronic measurement of compliance with mercaptopurine in pediatric patients with acute lymphoblastic leukemia. Med Pediatr Oncol. 1998;30(2):85–90.

Article  CAS  PubMed  Google Scholar 

Pizzo PA, Robichaud KJ, Edwards BK, Schumaker C, Kramer BS, Johnson A. Oral antibiotic prophylaxis in patients with cancer: a double-blind randomized placebo-controlled trial. J Pediatr. 1983;102(1):125–33.

Article  CAS  PubMed  Google Scholar 

Pai ALH, Drotar D, Kodish E. Correspondence Between Objective and Subjective Reports of Adherence Among Adolescents With Acute Lymphoblastic Leukemia. Child Health Care. 2008;37(3):225–35.

Article  Google Scholar 

Jaime-Pérez JC, Jiménez-Castillo RA, Pinzón-Uresti MA, et al. Real-world outcomes of treatment for acute lymphoblastic leukemia during adolescence in a financially restricted environment: results at a single center in Latin America. Pediatr Blood Cancer. 2017;64(7):e26396.

Article  Google Scholar 

Wu YP, Stenehjem DD, Linder LA, et al. Adherence to oral medications during maintenance therapy among children and adolescents with acute lymphoblastic leukemia: a medication refill analysis. J Pediatr Oncol Nurs. 2018;35(2):86–93.

Article  PubMed  Google Scholar 

Tebbi CK, Zevon MA, Richards ME, Cummings KM. Attributions of responsibility in adolescent cancer patients and their parents. J Cancer Educ. 1989;4(2):135–42.

Article  CAS  PubMed  Google Scholar 

Ganesan P, Sagar TG, Dubashi B, et al. Nonadherence to imatinib adversely affects event free survival in chronic phase chronic myeloid leukemia. Am J Hematol. 2011;86(6):471–4.

Article  PubMed  Google Scholar 

Chapman RH, Petrilla AA, Benner JS, Schwartz JS, Tang SS. Predictors of adherence to concomitant antihypertensive and lipid-lowering medications in older adults: a retrospective, cohort study. Drugs Aging. 2008;25(10):885–92.

Article  PubMed  Google Scholar 

van Bruggen R, Gorter K, Stolk RP, Zuithoff P, Klungel OH, Rutten GE. Refill adherence and polypharmacy among patients with type 2 diabetes in general practice. Pharmacoepidemiol Drug Saf. 2009;18(11):983–91.

Article  PubMed  Google Scholar 

Gray SL, Mahoney JE, Blough DK. Medication adherence in elderly patients receiving home health services following hospital discharge. Ann Pharmacother. 2001;35(5):539–45.

Article  CAS  PubMed  Google Scholar 

Murphy CC, Fullington HM, Alvarez CA, et al. Polypharmacy and patterns of prescription medication use among cancer survivors. Cancer. 2018;124(13):2850–7.

Article  PubMed  Google Scholar 

Parsons SK, Kumar AJ. Adolescent and young adult cancer care: Financial hardship and continued uncertainty. Pediatr Blood Cancer. 2019;66(4):e27587.

Article  PubMed  Google Scholar 

Smith AW, Keegan T, Hamilton A, et al. Understanding care and outcomes in adolescents and young adults with cancer: A review of the AYA HOPE study. Pediatr Blood Cancer. 2019;66(1):e2748